1887

Chapter 5 : Nontoxigenic O1 Infections in the United States

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Nontoxigenic O1 Infections in the United States, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap05-2.gif

Abstract:

During the past two decades, strains of nontoxigenic (NT) O1 have been isolated in several countries, including Bangladesh, Guam, Brazil, Peru, Japan, England, and the United States. This chapter summarizes the available epidemiologic, microbiologic, and clinical information on NT O1 isolates from humans in the United States received by the Centers for Disease Control and Prevention (CDC) between 1977 and 1991. NT of O group 1 is biochemically and serologically indistinguishable from toxigenic O1, the cause of epidemic cholera, but does not produce cholera toxin (CT). The elevated levels of cyclic AMP in the mucosal cells of the small bowel cause a cascade that ultimately results in hypersecretion of chloride and bicarbonate into the intestinal lumen and hence a net osmotic efflux of water. NT O1 isolates were associated with a broad spectrum of illnesses. Symptoms recorded in medical records and epidemiologic reporting forms showed that 6 (43%) of 14 patients were hospitalized but that none died. Public health practitioners should regard NT O1 as a potential human pathogen but not as a pathogen with the same lethality and epidemic potential as toxigenic O1.

Citation: Rodrigue D, Popovic T, Wachsmuth I. 1994. Nontoxigenic O1 Infections in the United States, p 69-76. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch5

Key Concept Ranking

Clinical and Public Health
1.5660353
Outer Membrane Proteins
0.584294
Vibrio cholerae
0.4283174
1.5660353
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Seasonal distribution and isolation sites of 14 NT O1 infections, United States, 1977 to 1991.

Citation: Rodrigue D, Popovic T, Wachsmuth I. 1994. Nontoxigenic O1 Infections in the United States, p 69-76. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818364.chap5
1. Almeida, R. J. 1990. Identification and differentiation of pathogenic and epidemic Vibrio cholerae O1 strains. Ph.D. dissertation. University of North Carolina, Chapel Hill.
2. Almeida, R. J.,, D. N. Cameron,, W. L. Cook,, and I. K. Wachsmuth. 1992. Vibriophage VcA-3 as an epidemic strain marker for the U.S. Gulf Coast V. cholerae O1 clone. J. Clin. Microbiol. 30: 300 304.
3. Almeida, R. J.,, F. W. Hickman-Brenner,, E. G. Sowers,, N. D. Puhr,, J. J. Farmer III,, and I. K. Wachsmuth. 1990. Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin. J. Clin. Microbiol. 28: 128 130.
4. Bhattacharya, S. K.,, M. K. Bhattacharya,, P. Dutta,, D. Dutta,, S. P. De,, S. N. Sikdar,, A. Maitra,, A. Dutta,, and S. C. Pal. 1990. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera. Antimicrob. Agents Chemother. 34: 939 940.
5. Centers for Disease Control. 1977. Vibrio cholerae—Alabama. Morbid. Mortal. Weekly Rep. 26: 159160.
6. Chen, E.,, G. M. Evins,, W. L. Cook,, R. Almeida,, N. Hargrett-Bean,, and I. K. Wachsmuth. 1991. Genetic diversity among toxigenic and nontoxigenic Vibro cholerae Ol isolated from the western hemisphere. Epidemiol. Infect. 107: 225 233.
7. Colwell, R. R.,, R. J. Seidler,, J. B. Kaper,, S. W. Joseph,, S. Garges,, H. Lockman,, D. Maneval,, H. Bradford,, N. Roberts,, E. Remmers,, I. Huq,, and A. Huq. 1981. Occurrence of Vibro cholerae serotype Ol in Maryland and Louisiana estuaries. Appl. Environ. Microbiol. 41: 555 557.
8. DiRita, V.,, C. Parsot,, G. Jander,, and J. J. Mekalanos. 1991. Regulatory cascade controls virulence in Vibrio cholerae. Proc. Natl. Acad. Sci USA 88: 5403 5407.
9. Falkow, S.,, and J. J. Mekalanos,. 1990. The enteric bacilli and vibrios, p. 561 587. In B. D. Davis (ed.), Microbiology, 4th ed. J. B. Lippincott Co., Philadelphia.
10. Fields, P. I.,, T. Popovic,, K. Wachsmuth, and 0. Olsvik. 1992. Use of polymerase chain reaction for detection of toxigenic Vibrio cholerae Ol strains from the Latin American cholera epidemic. J. Clin. Microbiol. 30: 2118 2121.
11. Goldberg, S.,, and J. R. Murphy. 1983. Molecular epidemiological studies of the United States Gulf Coast Vibrio cholerae strains: integration site of mutator vibriophage VcA-3. Infect. Immun. 42: 224 230.
12. Herrington, D. A.,, R. H. Hall,, G. Losonsky,, J. J. Mekalanos,, R. K. Taylor,, and M. M. Levine. 1988. Toxin, toxin coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J. Exp. Med. 168: 1487 1492.
13. Honda, S. I.,, K. Shimoirisa,, and A. Adachi. 1988. Clinical isolates of Vibrio cholerae Ol not producing cholera toxin. Lancet ii: 1486.
14. Hood, M. A.,, G. E. Ness,, and G. E. Rodrick. Isolation of Vibrio cholerae serotype Ol from the eastern oyster, Crassostrea virginica. Appl. Environ. Microbiol. 41: 559 560.
15. Johnston, J. M.,, L. M. McFarland,, H. B. Bradford,, and C. T. Caraway. 1983. Isolation of non-toxigenic Vibrio cholerae Ol from a human wound infection. J. Clin. Microbiol. 17: 918 920.
16. Kaper, J. B. 1989. Vibrio cholerae vaccines. Rev. Infect. Dis. Suppl 3: S568 S573.
17. Kaper, J. B. 1989. Vibrio cholerae vaccines. Rev. Infect. Dis. Suppl. 3: S568 S573.
18. Kelly, M. T.,, F. W. Hickman-Brenner,, and J. J. Farmer HI,. 1991. Vibrio, p. 384 395. In A. Ba-lows,, W. J. Hausler, Jr.,, K. L. Herrmann,, H. D. Isenberg,, and H. J. Shadomy (ed.), Manual of Clinical Microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
19. Klontz, K. C.,, R. V. Tauxe,, W. L. Cook,, W. H. Riley,, and I. K. Wachsmuth. 1987. Cholera after the consumption of raw oysters. Ann. Intern. Med. 107: 846 848.
20. Levine, M. M.,, R. E. Black,, M. L. Clements,, L. Cisneros,, A. Saah,, D. R. Nalin,, D. M. Gill,, J. P. Craig,, C. R. Young,, and P. Ristaino. 1982. The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup Ol biotype E. Tor isolated from sewage water in Brazil. J. Infect. Dis. 145: 296 299.
21. Levine, M. M.,, J. B. Kaper,, D. Herrington,, J. Ketley,, G. Losonsky,, C. O. Tacket,, B. Tall,, and S. Cryz. 1988. Safety, immunogenicity, and the efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103 HgR. Lancet 1: 467 470.
22. Morris, J. G.,, and R. E. Black. 1985. Cholera and other vibrioses in the United States. N. Engl. J. Med. 312: 343 350.
23. Morris, J. G.,, J. L. Picardi,, S. Lieb,, J. V. Lee,, A. Roberts,, M. Hood,, R. A. Gunn,, and P. A. Blake. 1984. Isolation of nontoxigenic Vibrio cholerae O group 1 from a patient with severe gastroinestinal disease. J. Clin. Microbiol. 19: 296 297.
24. Morris, J. G., Jr.,, J. H. Tenney,, and G. L. Drusano. 1985. In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents. Antimicrob. Agents Chemother. 28: 442 445.
25. Moyenuddin, M.,, K. Wachsmuth,, S. H. Richardson,, and W. L. Cook. 1992. Enteropatho-genicity of non-toxigenic Vibrio cholerae Ol for adult mice. Microb. Pathog. 12: 451 458.
26. O'Brien, A. D.,, M. E. Chen,, R. K. Holmes,, J. B. Kaper,, and M. M. Levine. 1984. Environmental and human isolates Vibrio cholerae and Vibrio parahemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. Lancet i: 77 78.
27. Peterson, K. M.,, R. K. Taylor,, V. I. Miller,, V. J. DiRita,, and J. J. Mekalanos,. 1988. Coordinate regulation of virulence determinants in Vibrio cholerae, p. 165 172. In M. Schwartz (ed.), Molecular biology and infectious diseases. Elsevier, Paris.
28. Popovic, T.,, C. A. Bopp,, Ø. Olsvik,, and I. K. Wachsmuth. 1993. A standardized ribotype scheme for Vibrio cholerae O1: epidemiologic application. J. Clin. Microbiol. 31: 2474 2482.
29. Richardson, S. H.,, J. C. Giles,, and K. S. Kruger. 1984. Sealed adult mice: new model for enterotoxin evaluation. Infect. Immun. 43: 482 486.
30. Sack, D. A.,, S. Huda,, P. K. B. Neogi,, R. R. Danial,, and W. M. Spira. 1980. Microtiter ganglioside enzyme-linked immunosorbent assay for Vibrio and Escherichia heat-labile enterotoxins and antioxin. J. Clin. Microbiol. 11: 35 40.
31. Sack, D. A.,, and R. B. Sack. 1975. Test for enterotoxigenic Escherichia coli using Yl adrenal cells in miniculture. Infect. Immun. 11: 334 336.
32. Safrin, S.,, J. G. Morris,, M. Adams,, V. Pons,, R. Jacobs,, and J. E. Conte, Jr. 1988. Non-O1 Vibrio cholerae bacteremia: case report and review. Rev. Infect. Dis. 10: 1012 1017.
33. Sanyal, S. C.,, K. Alam,, P. K. B. Neogi,, M. I. Huq,, and K. A. Al-Mahmud. 1983. A new cholera toxin. Lancet i: 1337.
34. Sanyal, S. C.,, P. K. B. Neogi,, K. Alam,, H. I. Huq,, and K. A. Al-Mahmud. 1984. A new enterotoxin produced by Vibrio cholerae Ol, J. Diarrheal Dis. Res. 2: 3 12.
35. Sigel, S. P.,, S. Lanier,, V. S. Baselski,, and C. D. Parker. 1980. In vivo evaluation of pathogenicity of clinical and environmental isolates of Vibrio cholerae. Infect. Immun. 28: 681 687.
36. Spira, W. M.,, D. A. Sack,, P. J. Fedorka-Cray,, S. Sanyal,, J. Madden,, and B. McCardeU,. 1986. Description of a possible new extracellular virulence factor in nontoxigenic Vibrio cholerae Ol, p. 263 270. In S. Kuwahara, and N. F. Pierce (ed.), Advances in research on cholera and related diarrheas, 3rd ed. KTK Scientific Publishers, Tokyo.
37. Wachsmuth, I. K.,, G. M. Evins,, P. I. fields,, O. Olsvik,, T. Popovic,, J. G. Wells,, C. Carrillo,, and P. A. Blake. 1993. The molecular epidemiology of cholera in Latin America. J. Infect. Dis. 167: 621 626.
38. Wallace, C. K.,, P. N. Anderson,, T. C. Brown,, S. R. Khanra,, G. W. Lewis,, N. F. Pierce,, S. N. Sanyal,, G. V. Segre,, and R. H. Waldman. 1968. Optimal antibiotic therapy in cholera. Bull W.H.O. 39: 239 245.
39. Yamomoto, K.,, Y. Ichinose,, N. Nakasone,, M. Tanabe,, M. Nagahama,, J. Sakurai,, and M. Iwanaga. 1986. Identity of hemolysins produced by Vibrio cholerae non-Ol and Vibrio cholerae Ol, biotype El Tor. Infect. Immun. 51: 927 937.

Tables

Generic image for table
Table 1

Laboratory characteristics of 14 NT O1 isolates, United States, 1977 to 1991

Citation: Rodrigue D, Popovic T, Wachsmuth I. 1994. Nontoxigenic O1 Infections in the United States, p 69-76. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch5
Generic image for table
Table 2

Genotypic characteristics of NT O1 strains

Citation: Rodrigue D, Popovic T, Wachsmuth I. 1994. Nontoxigenic O1 Infections in the United States, p 69-76. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch5
Generic image for table
Table 3

Features of 14 patients from whom NT O1 was isolated, United States, 1977 to 1991

Citation: Rodrigue D, Popovic T, Wachsmuth I. 1994. Nontoxigenic O1 Infections in the United States, p 69-76. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch5
Generic image for table
Table 4

Symptoms of 10 patients with NT O1 isolated from stool

Citation: Rodrigue D, Popovic T, Wachsmuth I. 1994. Nontoxigenic O1 Infections in the United States, p 69-76. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch5

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error